From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
Comorbidities
Patients, n (%) (n = 396)
Depression
53 (13.4)
Hypertension
34 (8.6)
Obesity
29 (7.3)
Anxiety
28 (7.1)
Somnolence
27 (6.8)
Blood prolactin increased
21 (5.3)
Extrapyramidal disorder
Weight increased
20 (5.1)